CITEL-CREATIVE Announces Board Approval of Application to Transfer to General Board and Concurrent Private Placement of New Shares with Existing Shareholders Waiving Preemptive Rights

1. Date of Board Resolution: August 10, 115 (2026) 2. Source of Capital Increase: Cash capital increase 3. Use of aggregate filing for issuance of new shares (Yes, specify planned issuance period / No): No 4. Total issuance amount and number of shares (excluding employee allocation for surplus or reserve capitalization): Undetermined 5. Issuance amount and number of shares for aggregate filing cases: Not applicable 6. Remaining amount and number of shares after issuance under aggregate filing: Not applicable 7. Par value per share: NT$10 8. Issuance price: Undetermined 9. Number of shares or amount allocated for employee subscription: In accordance with Article 267 of the Company Act, 10% to 15% of the shares are reserved for subscription by company employees. 10. Number of shares for public offering: Undetermined 11. Subscription ratio or free allocation for existing shareholders: The company proposes to request existing shareholders to fully waive their preemptive subscription rights, with all shares to be allocated to securities underwriters for public offering. 12. Handling of fractional shares and unclaimed shares: Shares not subscribed by employees may be assigned by the Chairman to specific investors. 13. Rights and obligations of the newly issued shares: Same as existing ordinary shares. 14. Purpose of raised capital: To strengthen working capital. 15. Rationality and necessity of fundraising after cash reduction (applicable if cash reduction was conducted in the current or previous year): Not applicable 16. Other matters to be disclosed: All details of the issuance plan (including but not limited to issuance price, actual number of shares, issuance conditions, project plans, fundraising amount, expected timeline, and anticipated benefits), as well as any future adjustments due to regulatory approval, management evaluation, or objective conditions, will be submitted to the shareholders' meeting for full authorization to the board of directors.